文献
J-GLOBAL ID:201902236352601689
整理番号:19A0177711
新しい負のアロステリック調節因子7-((2,5-ジオキソピロリジン-1-イル)メチル)-4-(2-フルオロ-4-[~11C]メトキシフェニル)キノリン-2-カルボアミド,代謝型グルタミン酸受容体2のイメージングのための))の合成と予備的研究【JST・京大機械翻訳】
Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[11C]methoxyphenyl) quinoline-2-carboxamide, for Imaging of Metabotropic Glutamate Receptor 2
著者 (20件):
Zhang Xiaofei
(Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Massachusetts, United States)
,
Zhang Xiaofei
(Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Zhang Xiaofei
(State Key Laboratory and Institute of Elemento-Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering, Nankai University, China)
,
Kumata Katsushi
(Department of Radiopharmaceutics Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Yamasaki Tomoteru
(Department of Radiopharmaceutics Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Cheng Ran
(Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Massachusetts, United States)
,
Cheng Ran
(Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Hatori Akiko
(Department of Radiopharmaceutics Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Ma Longle
(Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Massachusetts, United States)
,
Ma Longle
(Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Zhang Yiding
(Department of Radiopharmaceutics Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Xie Lin
(Department of Radiopharmaceutics Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Wang Lu
(Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Massachusetts, United States)
,
Wang Lu
(Department of Radiology, Harvard Medical School, Massachusetts, United States)
,
Kang Hye Jin
(Department of Pharmacology & National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina at Chapel Hill, North Carolina, United States)
,
Sheffler Douglas J.
(Cancer Metabolism and Signaling Networks Program and Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Prebys Medical Discovery Institute, California, United States)
,
Cosford Nicholas D. P.
(Cancer Metabolism and Signaling Networks Program and Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Prebys Medical Discovery Institute, California, United States)
,
Zhang Ming-Rong
(Department of Radiopharmaceutics Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan)
,
Liang Steven H.
(Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Massachusetts, United States)
,
Liang Steven H.
(Department of Radiology, Harvard Medical School, Massachusetts, United States)
資料名:
ACS Chemical Neuroscience
(ACS Chemical Neuroscience)
巻:
8
号:
9
ページ:
1937-1948
発行年:
2017年
JST資料番号:
W5038A
ISSN:
1948-7193
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)